Labs
Supplements
Log in
Register
Scan Me!
A study in more than 22,000 women reports a weak signal of breast-cancer risk with insulin glargine vs NPH insulin, but the researchers caution that this should not change clinical practice.
Source: Insulin Glargine/Breast Cancer Link Seen Again in Type 2 Diabetes
